AbCellera Biologics Inc.

Information about the Issuer

Trading symbol
ABCL
Security kind
share
Security category and type
ordinary share
ISIN
CA00288U1066
CFI code, ISO 10962:2015
ESVUFR
Par value
no par value
Par value currency
-
Recognised trading venue
The NASDAQ Stock Market LLC
Admitted to trading, or retained on the list of qualified investments admitted to trading despite of failure to comply with ITS Rules on admission to trading
No

Issuer's website
www.abcellera.com
Investor relations section of Issuer's website
https://investors.abcellera.com/overview/default.aspx
Information published on the website of the regulatory body, and/or a duly authorized disclosure agency ^[1]
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1703057
Information disclosed on the website of the recognised trading venue
http://www.nasdaq.com/symbol/ABCL
Annual reports ^[2]
https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=1703057&type=10-k

Date of admission to trading
07.06.2023
Trading modes
Main Trading Mode, Negotiated Transaction Mode, Negotiated repurchase with the Central Counterparty, RFQ Trading Mode
Instrument group
US Market Securities
Lot
1
Price tick
0.01
Price currency
USD
Settlement currency
USD

If necessary switch to the English version of the website and/or search by issuer's full name (refer to "Full name" field in the section "Information about Issuer") and, if applicable, indicate the search period, with regard to the supported time range
Annual reports disclosed after the date of admission to trading on the recognised trading venue, or for the last three years, if admitted to trading earlier than 3 years ago